HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Michihiro Mutoh Selected Research

3,4,11- trihydroxy- 2- (hydroxymethyl)- 8- (4- hydroxyphenyl)- 3,4,4a,11b- tetrahydro- 2H,10H- pyrano(2',3'- 4,5)furo(3,2- g)chromen- 10- one

4/2006

Inhibition of intestinal carcinogenesis by a new flavone derivative, chafuroside, in oolong tea.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research network!

Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:

1 year subscription, $45.00 USD

Request Bulk Institution License Details >>

Michihiro Mutoh Research Topics

Disease

15	Neoplasms (Cancer) 07/2010 - 01/2002
8	Intestinal Polyps 12/2009 - 02/2005
8	Colonic Neoplasms (Colon Cancer) 10/2006 - 01/2002
5	Hyperlipidemias (Hyperlipidemia) 10/2007 - 02/2005
3	Pancreatic Neoplasms (Pancreatic Cancer) 07/2010 - 08/2007
3	Adenocarcinoma 08/2008 - 05/2005
3	Carcinoma (Carcinomatosis) 10/2006 - 04/2002
2	Body Weight (Weight, Body) 07/2010 - 10/2006
2	Colorectal Neoplasms (Colorectal Cancer) 12/2008 - 03/2006
1	Polyps 12/2009
1	Hypertriglyceridemia 04/2008
1	Diabetes Mellitus 10/2007
1	Type 2 Diabetes Mellitus (MODY) 10/2007
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2007
1	Tongue Neoplasms (Tongue Neoplasm) 03/2007
1	Adenoma (Adenomas) 12/2006
1	Inflammation 01/2006
1	Osteosarcoma (Osteogenic Sarcoma) 01/2005
1	Papilloma (Papillomatosis) 01/2005

Drug/Important Bio-Agent (IBA)

7	Messenger RNA (mRNA)IBA 12/2009 - 01/2002
3	nitrosobis(2-oxopropyl)amine (NBOP)IBA 07/2010 - 08/2007
3	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 12/2009 - 02/2005
3	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2008 - 03/2002
3	PPAR alphaIBA 10/2007 - 02/2005
3	PPAR gammaIBA 08/2007 - 02/2005
3	Prostaglandins E (PGE)IBA 03/2007 - 01/2002
3	AzoxymethaneIBA 10/2006 - 05/2005
2	7- chloro- 3- imino- 5- methyl- 2- azabicyclo(4.1.0)heptaneIBA 08/2008 - 03/2006
2	Triglycerides (Triacylglycerol)IBA 10/2007 - 12/2006
2	pioglitazone (Actos)FDA Link 08/2007 - 04/2006
2	ONO 8711IBA 03/2007 - 05/2005
2	4- diethoxyphosphorylmethyl- N- (4- bromo- 2- cyanophenyl)benzamideIBA 04/2006 - 02/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2005 - 01/2005
2	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 05/2005 - 04/2002
1	Contrast MediaIBA 07/2010
1	Scopolamine (Hyoscine)FDA Link 07/2010
1	butyl bromideIBA 07/2010
1	Iopamidol (Isovue)FDA LinkGeneric 07/2010
1	oil red OIBA 12/2009
1	LDL Receptors (LDL Receptor)IBA 12/2009
1	Oleic AcidsIBA 12/2008
1	Linoleic Acid (Linoleate)IBA 12/2008
1	Arachidonic AcidsIBA 12/2008
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2008
1	Arachidonic Acid (Vitamin F)IBA 12/2008
1	Urethane (Ethyl Carbamate)IBA 09/2008
1	AdipokinesIBA 04/2008
1	Plasminogen Activators (Plasminogen Activator)IBA 04/2008
1	Plasminogen Activator Inhibitor 1IBA 04/2008
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2007
1	Indomethacin (Indometacin)FDA LinkGeneric 10/2007
1	LipidsIBA 10/2007
1	Cyclooxygenase 1IBA 10/2006
1	mofezolac (N 22)IBA 10/2006
1	3,4,11- trihydroxy- 2- (hydroxymethyl)- 8- (4- hydroxyphenyl)- 3,4,4a,11b- tetrahydro- 2H,10H- pyrano(2',3'- 4,5)furo(3,2- g)chromen- 10- oneIBA 04/2006
1	BezafibrateIBA 04/2006
1	Dinoprostone (PGE2)FDA Link 01/2006
1	ProstaglandinsIBA 01/2006
1	Doxycycline (Vibramycin)FDA LinkGeneric 11/2005
1	Carbon MonoxideIBA 11/2005
1	Chloride Channels (Chloride Channel)IBA 11/2005
1	Bromodeoxyuridine (BrdU)IBA 05/2005
1	Proteins (Proteins, Gene)IBA 01/2005
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2005
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2003
1	NF-kappa B (NF-kB)IBA 10/2003
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2002
1	Butyrates (Butyrate)IBA 03/2002
1	SodiumIBA 03/2002
1	ONO-AE1-329IBA 01/2002

Therapy/Procedure

1	Chemoprevention 01/2006
1	Transplants (Transplant) 01/2005